ArticleNPJ precision oncology2026

Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer.

Xiao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.